1. Application of permeability‐limited physiologically‐based pharmacokinetic models: Part II ‐ prediction of p‐glycoprotein mediated drug–drug interactions with digoxin. Issue 9 (19th May 2013) Authors: Neuhoff, Sibylle; Yeo, Karen Rowland; Barter, Zoe; Jamei, Masoud; Turner, David B.; Rostami‐Hodjegan, Amin; Nakashima, Emi; Brouwer, Kim; Hammarlund‐Udenaes, Margareta; Terasaki, Tetsuya Journal: Journal of pharmaceutical sciences Issue: Volume 102:Issue 9(2013:Sep.) Page Start: 3161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Application of permeability‐limited physiologically‐based pharmacokinetic models: Part I–digoxin pharmacokinetics incorporating P‐glycoprotein‐mediated efflux. Issue 9 (22nd May 2013) Authors: Neuhoff, Sibylle; Yeo, Karen Rowland; Barter, Zoe; Jamei, Masoud; Turner, David B.; Rostami‐Hodjegan, Amin; Nakashima, Emi; Brouwer, Kim; Hammarlund‐Udenaes, Margareta; Terasaki, Tetsuya Journal: Journal of pharmaceutical sciences Issue: Volume 102:Issue 9(2013:Sep.) Page Start: 3145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Application of proteomic data in the translation of in vitro observations to associated clinical outcomes. (December 2021) Authors: Neuhoff, Sibylle; Harwood, Matthew D.; Rostami-Hodjegan, Amin; Achour, Brahim Journal: Drug discovery today Issue: Volume 39(2021) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessing Potential Drug–Drug Interactions Between Dabigatran Etexilate and a P‐Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling. (25th February 2019) Authors: Doki, Kosuke; Neuhoff, Sibylle; Rostami‐Hodjegan, Amin; Homma, Masato Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 8:Number 2(2019) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective. Issue 3 (21st June 2022) Authors: Chu, Xiaoyan; Prasad, Bhagwat; Neuhoff, Sibylle; Yoshida, Kenta; Leeder, James Steven; Mukherjee, Dwaipayan; Taskar, Kunal; Varma, Manthena V. S.; Zhang, Xinyuan; Yang, Xinning; Galetin, Aleksandra Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 3(2022) Page Start: 501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective. Issue 3 (22nd June 2022) Authors: Taskar, Kunal S.; Yang, Xinning; Neuhoff, Sibylle; Patel, Mitesh; Yoshida, Kenta; Paine, Mary F.; Brouwer, Kim L.R.; Chu, Xiaoyan; Sugiyama, Yuichi; Cook, Jack; Polli, Joseph W.; Hanna, Imad; Lai, Yurong; Zamek‐Gliszczynski, Maciej Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 3(2022) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH). Issue 2 (2nd June 2022) Authors: Murphy, William A.; Adiwidjaja, Jeffry; Sjöstedt, Noora; Yang, Kyunghee; Beaudoin, James J.; Spires, Jessica; Siler, Scott Q.; Neuhoff, Sibylle; Brouwer, Kim L.R. Journal: Clinical pharmacology & therapeutics Issue: Volume 113:Issue 2(2023) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data. Issue 3 (June 2016) Authors: Gaohua, Lu; Neuhoff, Sibylle; Johnson, Trevor N.; Rostami-Hodjegan, Amin; Jamei, Masoud Journal: Drug metabolism and pharmacokinetics Issue: Volume 31:Issue 3(2016) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer. (25th February 2016) Authors: Walsh, Christopher; Bonner, Jennifer J.; Johnson, Trevor N.; Neuhoff, Sibylle; Ghazaly, Essam A.; Gribben, John G.; Boddy, Alan V.; Veal, Gareth J. Journal: British journal of clinical pharmacology Issue: Volume 81:Number 5(2016:May) Page Start: 989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Development of a physiologically based pharmacokinetic model to predict the effects of flavin‐containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure. (28th May 2017) Authors: Zhou, Wangda; Humphries, Helen; Neuhoff, Sibylle; Gardner, Iain; Masson, Eric; Al‐Huniti, Nidal; Zhou, Diansong Journal: Biopharmaceutics & drug disposition Issue: Volume 38:Number 6(2017:Sep.) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗